MIGRAINE management: The recent down-scheduling of some medications in the triptan class to Pharmacist Only medicines has increased the scope of migraine management that pharmacists can offer to patients.
Determining the most appropriate treatment option requires consideration of patient history, symptom presentation and previous treatment regimen.
Guild Learning and Development has partnered with GSK to develop an education module titled 'Primary care management of migraine'.
This module educates pharmacists on the best-practice management of migraine while focusing on the role of simple analgesia and other non-prescription options for patients.
The inclusion of case studies will help crystalise the role of each available medication class in the management of migraine in community pharmacy.
To enrol in this course please visit guilded.guild.org.au.
Please contact Guild Learning and Development on 1800 049 056 or email learninganddevelopment@guild.org.au for more information.
Guild Learning and Development thanks GSK for its financial support in developing this module.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Jul 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Jul 21
